29.10.2014 Views

The Hemi-Mustard/Bidirectional Glenn Atrial Switch in the Anatomic ...

The Hemi-Mustard/Bidirectional Glenn Atrial Switch in the Anatomic ...

The Hemi-Mustard/Bidirectional Glenn Atrial Switch in the Anatomic ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>The</strong> <strong>Hemi</strong>­<strong>Mustard</strong>/<strong>Bidirectional</strong><br />

<strong>Glenn</strong> <strong>Atrial</strong> <strong>Switch</strong> <strong>in</strong> <strong>the</strong><br />

<strong>Anatomic</strong> Repair of cc­TGA:<br />

Rationale and Midterm Results<br />

S.P. Malhotra, V.M. Reddy, M. Qiu,<br />

T. Pirolli, L. Barboza, O. Re<strong>in</strong>hartz, F.L. Hanley


No relationships to disclose


<strong>Anatomic</strong> repair of cc­TGA<br />

• Support <strong>the</strong> systemic<br />

circulation with <strong>the</strong><br />

morphological left ventricle<br />

• Indication for <strong>in</strong>tervention<br />

– Decreased morphologic RV<br />

function<br />

– Progressive tricuspid<br />

regurgitation<br />

– VSD and/or PS, PA


OUR STRATEGY: Optimize outcomes of anatomic<br />

correction of ccTGA with <strong>the</strong> bidirectional <strong>Glenn</strong><br />

–RV Unload<strong>in</strong>g may<br />

•Lessen impact of RV dysfunction<br />

•Prolong life of RV­PA conduit<br />

•Decrease tricuspid regurgitation<br />

–Simplify<strong>in</strong>g atrial baffle may<br />

•Reduce s<strong>in</strong>us node dysfunction and atrial dysrhythmias<br />

•Reduce systemic and pulmonary venous pathway<br />

obstruction<br />

•Be helpful with positional anomalies such as situs solitus<br />

with dextrocardia, mesocardia and situs <strong>in</strong>versus


Patients<br />

•48 patients between Jan 1993 to Sept 2009<br />

•Rastelli­atrial switch (RAS): 25<br />

–Pulmonary atresia: 22 (4 with PA/MAPCAs)<br />

–Severe subpulmonary stenosis: 3<br />

•Arterial­atrial switch (AAS): 23<br />

–PAB required: 17<br />

–PAB tightened: 8


<strong>Anatomic</strong> Details<br />

• Morphology<br />

–Positional anomalies <strong>in</strong> 35% (17/48)<br />

–[S,L,L] 42<br />

•Dextrocardia: 10<br />

•Mesocardia: 1<br />

–[I,D,D] 6<br />

• VSD: 40<br />

• Congenital HB: 4<br />

• Tricuspid valve anomalies: 22<br />

– Moderate or greater TR: 20<br />

– Ebste<strong>in</strong>oid valve: 10


Age distribution<br />

20<br />

18<br />

16<br />

14<br />

12<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

< 1 yr 1­5 yr 5­10 yr 10­15 yr > 15 yr<br />

•Median age 3.0 years<br />

•Range 3.9 months to 24.0 years


Pre­DSO Procedures<br />

Arterial­atrial group<br />

Rastelli­atrial group<br />

Pulmonary artery band 17 Modified Blalock­Taussig Shunt 17<br />

PA Band tighten<strong>in</strong>g 8 Second Modified Blalock­Taussig Shunt 5<br />

<strong>Bidirectional</strong> <strong>Glenn</strong> 2<br />

VSD repair 1<br />

Aortopulmonary w<strong>in</strong>dow prior to<br />

unifocalization<br />

Unifocalization of MAPCAs to central<br />

shunt<br />

2<br />

4<br />

Pacemaker implantation 3 <strong>Bidirectional</strong> <strong>Glenn</strong> 5<br />

Pacemaker implantation 1


Arterial­<strong>Atrial</strong> <strong>Switch</strong> (AAS)<br />

Rastelli­<strong>Atrial</strong> <strong>Switch</strong> (RAS)<br />

<strong>The</strong> “<strong>Hemi</strong>­<strong>Mustard</strong>” patch is always a simple circle, which<br />

bends appropriately around <strong>the</strong> TV annulus and IVC orifice


<strong>Hemi</strong>­<strong>Mustard</strong> <strong>Atrial</strong> <strong>Switch</strong><br />

•Performed <strong>in</strong> 33/48 (70%) patients<br />

•Conventional atrial baffle performed <strong>in</strong> 15<br />

–Elevated PVR— 5 cases<br />

–<strong>Anatomic</strong> considerations (LSVC to coronary s<strong>in</strong>us)­2 pts<br />

–Surgeon preference— 8 pts (6 performed <strong>in</strong> <strong>the</strong> early<br />

experience)


Outcomes<br />

•Hospital mortality: 2.1% (1/48)<br />

•No late deaths<br />

•Postoperative ECMO support required <strong>in</strong> 2<br />

patients<br />

•Postoperative heart block: 21% (10/48)


Midterm results<br />

100% complete follow­up<br />

•Median follow­up 4.9 y, range 7 m ­ 16 y<br />

•Biventricular function preserved <strong>in</strong> 87% of<br />

survivors<br />

–LV dysfunction:<br />

moderate— 4 (2 AAS)<br />

severe— 2<br />

(2 AAS)<br />

•NYHA functional class I <strong>in</strong> 43/47<br />

•All acyanotic<br />

•None have required cardiac transplantation


<strong>Hemi</strong>­<strong>Mustard</strong> results<br />

• No baffle obstruction (0/33)<br />

– Senn<strong>in</strong>g/<strong>Mustard</strong> experience: 5­15% 1,2<br />

• No s<strong>in</strong>us node dysfunction (0/33)<br />

– Senn<strong>in</strong>g/<strong>Mustard</strong> experience 35­46% 3,4<br />

• 1 atrial tachyarrhythmia req ablation (1/33)<br />

– Senn<strong>in</strong>g/<strong>Mustard</strong> experience 8­15% 3,4<br />

• 2 BDG complications (Both age < 4 mo)<br />

– takedown due to circular shunt<br />

– neurologic complication­choreoa<strong>the</strong>tosis<br />

1<br />

Helb<strong>in</strong>g, et al. J Thorac Cardiovasc Surg. 1994;108:363­71.<br />

2<br />

Williams, et al. J Thorac Cardiovasc Surg. 1988;95:717­23.<br />

3<br />

Fl<strong>in</strong>n, et al. N Engl J Med. 1984;310:1635­42.<br />

4<br />

Dos, et al. Heart. 2005;91:652­6.


Outcomes: TR<br />

p=0.00004<br />

•TR grade decreased from 2.2 ± 1.0 to 1.3 ± 0.5<br />

•Post­DS TR was not affected if BDG used


Outcomes: Reoperation<br />

• AAS­higher earlier need for reoperation<br />

• RAS­late reoperation due to RV to PA<br />

conduit replacement


Arterial­atrial switch outcomes<br />

• Coronary complications: 2/23<br />

– Reop LeCompte/LCA release performed<br />

– Severe proximal RCA stenosis<br />

• Neo­Aortic <strong>in</strong>sufficiency: 2/23<br />

– AVR required <strong>in</strong> one patient<br />

– Both had PAB<br />

30<br />

25<br />

• At higher risk for decreased<br />

NYHA functional status<br />

compared to Rastelli group<br />

(p=0.013)<br />

20<br />

15<br />

10<br />

5<br />

0<br />

RAS<br />

AAS<br />

IV<br />

III<br />

II<br />

I


Rastelli­atrial switch outcomes:<br />

RVOT revision<br />

• <strong>Hemi</strong>­<strong>Mustard</strong> group: 100% 10­yr freedom from RVOT<br />

<strong>in</strong>tervention<br />

• Conventional atrial switch: 75% 5­yr and 50% 10­yr<br />

• <strong>Hemi</strong>­<strong>Mustard</strong> lower risk of RVOT re<strong>in</strong>tervention (p=0.019)


Conclusions<br />

• <strong>The</strong> double switch with <strong>the</strong> BDG can be performed<br />

with low morbidity and mortality<br />

• <strong>Hemi</strong>­<strong>Mustard</strong> should be avoided <strong>in</strong> <strong>the</strong> youngest<br />

patients that are at high risk for elevated PVR<br />

• Advantages of <strong>the</strong> <strong>Hemi</strong>­<strong>Mustard</strong>:<br />

–Decreases volume across RVOT and prolongs life<br />

of RV to PA conduit<br />

–Baffle complications m<strong>in</strong>imized<br />

–S<strong>in</strong>us node dysfunction m<strong>in</strong>imized<br />

–Unloads <strong>the</strong> fail<strong>in</strong>g right ventricle<br />

–Simplifies <strong>the</strong> atrial baffle technique

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!